<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Rosen Law Firm, a global investor rights law firm, reminds purchasers of 
 the American Depositary Shares of Desarrolladora Homex, S.A.B. de C.V. 
 a/k/a Homex Development Corp. (formerly NYSE: HXM; formerly OTCMKTS: 
 DHOXQ; formerly OTCMKTS: DHOXY) from April 30, 2012 through May 5, 2016, 
 both dates inclusive (the "Class Period") of the important May 15, 2017 
 lead plaintiff deadline. The lawsuit seeks to recover damages for Homex 
 investors under the federal securities laws.
 
 
 To join the Homex class action, go to <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-1076.html&amp;esheet=51528752&amp;newsitemid=20170320006258&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-1076.html&amp;index=1&amp;md5=2d904dc169ad6302f1d1f57eeff25c9c" rel="nofollow" rel="nofollow">http://www.rosenlegal.com/cases-1076.html</a> 
 or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 
 or email <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:pkim@rosenlegal.com" rel="nofollow" rel="nofollow">pkim@rosenlegal.com</a> or <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:kchan@rosenlegal.com" rel="nofollow" rel="nofollow">kchan@rosenlegal.com</a> 
 for information on the class action.
 
 
 NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS 
 CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU 
 MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU 
 MAY RETAIN COUNSEL OF YOUR CHOICE.
 
 
 According to the lawsuit, defendants throughout the Class Period made 
 false and/or misleading statements and/or failed to disclose that: (1) 
 between 2010 and 2013, Homex overstated its revenue by 355% or roughly 
 $3.3 billion by reporting fictitious sales of more than 100,000 homes; 
 (2) between 2010 and 2013, Homex overstated the number of units it sold 
 by over 100,000 units or 317% of actual units sold; (3) Homex and 
 certain of its Headquarters Financial Reporting Personnel knowingly and 
 intentionally engaged in a scheme to materially overstate Homex's 
 revenues, homes sold, and other related financial items; and (4) as a 
 result, defendants' statements about Homex's business, operations and 
 prospects were materially false and misleading and/or lacked a 
 reasonable bases at all relevant times. When the true details entered 
 the market, the lawsuit claims that investors suffered damages.
 
 
 A class action lawsuit has already been filed. If you wish to serve as 
 lead plaintiff, you must move the Court no later than May 15, 2017. If 
 you wish to join the litigation, go to <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-1076.html&amp;esheet=51528752&amp;newsitemid=20170320006258&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.rosenlegal.com%2Fcases-1076.html&amp;index=2&amp;md5=1443eb93ca07ac47a76357809be47347" rel="nofollow" rel="nofollow">http://www.rosenlegal.com/cases-1076.html</a> 
 or to discuss your rights or interests regarding this class action, 
 please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 
 866-767-3653 or via email at <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:pkim@rosenlegal.com" rel="nofollow" rel="nofollow">pkim@rosenlegal.com</a> 
 or <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:kchan@rosenlegal.com" rel="nofollow" rel="nofollow">kchan@rosenlegal.com</a>.
 
 
 Follow us for updates on LinkedIn: <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;esheet=51528752&amp;newsitemid=20170320006258&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;index=3&amp;md5=d7296a4a78513575ac541aab6e2554b1" rel="nofollow" rel="nofollow">https://www.linkedin.com/company/the-rosen-law-firm</a> 
 or on Twitter: <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;esheet=51528752&amp;newsitemid=20170320006258&amp;lan=en-US&amp;anchor=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;index=4&amp;md5=bece1b69602c6b098d6e088d28a9dc76" rel="nofollow" rel="nofollow">https://twitter.com/rosen_firm</a>.
 
 
 Rosen Law Firm represents investors throughout the globe, concentrating 
 its practice in securities class actions and shareholder derivative 
 litigation. Attorney Advertising. Prior results do not guarantee a 
 similar outcome.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170320006258r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170320006258/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170320006258/en/</a></body></html>

Press Releases

NOTICE: Rosen Law Firm Reminds Desarrolladora Homex, S.A.B. de C.V. a/k/a Homex Development Corp. Investors of Important Deadline in Class Action – formerly HXM, DHOXQ, DHOXY 

DHOXY

NOTICE: Rosen Law Firm Reminds Desarrolladora Homex, S.A.B. de C.V. a/k/a Homex Development Corp. Investors of Important Deadline in Class Action – formerly HXM, DHOXQ, DHOXY

BMV:FIBRAMQ


► Acceleration of industrial growth capex program; acquisition of strategic, 25-hectare, industrial land bank in Monterrey to develop 906 thousand square feet of GLA


► Record quarterly results for consolidated revenue

FIBRA Macquarie México Reports First Quarter 2024 Results


Regulatory News:


Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing

Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting

PARIS:FR



Dassault Systèmes and Stellantis&#39; Peugeot Sport partnered to optimize the aerodynamics of the PEUGEOT 9X8 Hybrid Hypercar for the 2024 World Endurance Championship season



Dassault Systèmes&#39; SIMULIA applications

Peugeot Sport Aims for the Endurance Racing Finish Line With Simulation From Dassault Systèmes

BMV:ORBIA


Orbia Advance Corporation, S.A.B. de C.V. (BMV:ORBIA) (&#34;the Company&#34; or &#34;Orbia&#34;) today released unaudited results for the first quarter of 2024.


Orbia&#39;s first quarter performance reflects the continued weakness in the

Orbia Announces First Quarter 2024 Financial Results


AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an

AHF Praises Colombia for Putting Lives Before Pharma Greed


Freeport-McMoRan Inc. (NYSE:FCX) today announced the publication of its 2023 Annual Report on Sustainability detailing its environmental, social and governance performance during the year. This report marks FCX&#39;s 23rd